OA
IRWD icon

Oracle Alpha’s Ironwood Pharmaceuticals IRWD Stock Holding History

Oracle Alpha’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$103K Sell
11,804
-3,371
-22% -$40.9K 0.18% 173
2023
Q4 		$174K Buy
+15,175
New +$150K 0.22% 205

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Oracle Alpha's IRWD Position: Q1 2024 in Review

Oracle Alpha reduced its Ironwood Pharmaceuticals (IRWD) stake by 22% in Q1 2024, selling an estimated $40.9K and leaving 11,804 shares worth $103K. The position accounts for 0.18% of the portfolio, ranked #173.

Oracle Alpha first reported a position in IRWD in Q4 2023 and has held it in 2 quarters since. The position peaked at $174K in Q4 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Oracle Alpha held 11,804 shares of Ironwood Pharmaceuticals worth $103K as of Q1 2024.
  • Oracle Alpha sold 3,371 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $40.9K.
  • Ironwood Pharmaceuticals made up 0.18% of Oracle Alpha's portfolio in Q1 2024, its #173 holding.
  • Oracle Alpha first reported a position in Ironwood Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • Oracle Alpha's Ironwood Pharmaceuticals position peaked at $174K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.